Clinical Trials on Mild to Moderate Psoriasis in Korea, Democratic People's Republic of
Total 29 results
-
Bristol-Myers SquibbNot yet recruitingModerate-to-severe Plaque PsoriasisKorea, Republic of
-
Kyowa Kirin Korea Co., Ltd.CompletedModerate to Severe Plaque PsoriasisKorea, Republic of
-
PfizerCompletedModerate to Severe PsoriasisKorea, Republic of
-
GC Cell CorporationRecruitingClinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With PsoriasisModerate to Severe Plaque PsoriasisKorea, Republic of
-
UCB Biopharma SRLCompletedModerate to Severe Plaque PsoriasisKorea, Republic of
-
Dong-A ST Co., Ltd.CompletedMild to Moderate Onychomycosis Due to DermatophyteKorea, Republic of
-
EuBiologics Co.,LtdCompletedModerate to Severe Glabellar LinesKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedModerate to Severe Glabellar LineKorea, Republic of
-
PfizerRecruitingActive Psoriatic Arthritis | Active Ankylosing Spondylitis | Active Moderate to Severe Rheumatoid ArthritisKorea, Republic of
-
Samsung Medical CenterUnknownMild to Moderate Alzheimer DiseaseKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.TerminatedMild to Moderate COVID-19Korea, Republic of
-
SamA Pharmaceutical Co., LtdCompleted
-
Samsung Bioepis Co., Ltd.CompletedPsoriasis | Moderate to Severe Plaque PsoriasisCzechia, Estonia, Hungary, Korea, Republic of, Latvia, Lithuania, Poland, Ukraine
-
Asan Medical CenterSuspendedCoronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Mild to Moderate COVID-19Korea, Republic of
-
Nu Eyne Co., Ltd.RecruitingEarly to Moderate Dry Age-Related Macular DegenerationKorea, Republic of
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
Yonsei UniversityRecruitingModerate to Severe Dry EyeKorea, Republic of
-
Hyundai Pharmaceutical Co., LTD.RecruitingModerate-to-severe Alzheimer's DiseaseKorea, Republic of
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
Novartis PharmaceuticalsCompletedPatients With Moderate-to-severe COPD With Destroyed Lung by TuberculosisKorea, Republic of
-
Daehwa Pharmaceutical Co., Ltd.CompletedMild-moderate Alzheimer's DiseaseKorea, Republic of
-
CinnagenCompletedAllergic Asthma | Uncontrolled Moderate to SevereIran, Islamic Republic of
-
Incyte CorporationRecruitingModerate to Severe AsthmaKorea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate to Severe Persistent AsthmaUnited States, China, Hungary, Korea, Republic of, Poland
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom